DE69113273D1 - Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte. - Google Patents

Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.

Info

Publication number
DE69113273D1
DE69113273D1 DE69113273T DE69113273T DE69113273D1 DE 69113273 D1 DE69113273 D1 DE 69113273D1 DE 69113273 T DE69113273 T DE 69113273T DE 69113273 T DE69113273 T DE 69113273T DE 69113273 D1 DE69113273 D1 DE 69113273D1
Authority
DE
Germany
Prior art keywords
spectrin
bdp
sample
testing
separated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69113273T
Other languages
English (en)
Other versions
DE69113273T2 (de
Inventor
Gary Lynch
David Eveleth
Peter Seubert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of DE69113273D1 publication Critical patent/DE69113273D1/de
Application granted granted Critical
Publication of DE69113273T2 publication Critical patent/DE69113273T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
DE69113273T 1990-07-26 1991-07-11 Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte. Expired - Fee Related DE69113273T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/558,700 US5118606A (en) 1988-09-02 1990-07-26 Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products
PCT/US1991/004910 WO1992001935A1 (en) 1990-07-26 1991-07-11 Cell necrosis detection through assays for spectrin and breakdown products thereof

Publications (2)

Publication Number Publication Date
DE69113273D1 true DE69113273D1 (de) 1995-10-26
DE69113273T2 DE69113273T2 (de) 1996-05-15

Family

ID=24230602

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69113273T Expired - Fee Related DE69113273T2 (de) 1990-07-26 1991-07-11 Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.

Country Status (10)

Country Link
US (1) US5118606A (de)
EP (1) EP0540591B1 (de)
JP (2) JP2824150B2 (de)
AT (1) ATE128233T1 (de)
CA (1) CA2088050A1 (de)
DE (1) DE69113273T2 (de)
DK (1) DK0540591T3 (de)
ES (1) ES2077863T3 (de)
GR (1) GR3017459T3 (de)
WO (1) WO1992001935A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
US5536639A (en) * 1994-03-25 1996-07-16 Cephalon, Inc. Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
CA2188816C (en) * 1996-04-23 2009-09-22 Takeda Chemical Industries, Ltd. Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein
US6011991A (en) * 1998-12-07 2000-01-04 Technology Patents, Llc Communication system and method including brain wave analysis and/or use of brain activity
JP2005538380A (ja) * 2002-09-11 2005-12-15 ユニヴァーシティ オヴ フロリダ 神経細胞損傷の分析
EP2207033B1 (de) 2004-04-15 2014-06-18 University of Florida Research Foundation, Inc. Neuralproteine als Biomarker für Verletzungen des Nervensystems und anderen neuralen Störungen
US8492107B2 (en) * 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
JP4885122B2 (ja) * 2004-04-15 2012-02-29 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 癌、器官傷害、および筋肉リハビリテーション／運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー
WO2008097618A1 (en) * 2007-02-06 2008-08-14 University Of Florida Research Foundation, Inc. Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
JP2010536388A (ja) 2007-08-30 2010-12-02 ザ ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ 樹状細胞マーカーおよびその使用法
CA2755983A1 (en) * 2009-03-23 2010-09-30 The Walter And Eliza Hall Institute Of Medical Research Compounds and methods for modulating an immune response
CA2774411A1 (en) * 2009-09-18 2011-03-24 Geert W. Schmid-Schonbein Methods for detecting autodigestion
EP2621521A4 (de) 2010-10-02 2014-04-23 Univ California Minimierung von darmdysfunktionen
WO2012170669A1 (en) * 2011-06-07 2012-12-13 Yale University Avenue Biomarkers for assessment of the molecular quality in biospecimens
WO2019060298A1 (en) 2017-09-19 2019-03-28 Neuroenhancement Lab, LLC METHOD AND APPARATUS FOR NEURO-ACTIVATION
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
WO2020056418A1 (en) 2018-09-14 2020-03-19 Neuroenhancement Lab, LLC System and method of improving sleep
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US20230003741A1 (en) * 2019-11-26 2023-01-05 Ohio State Innovation Foundation Methods and compositions for cardiovascular disease detection and management

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2566327B2 (ja) * 1988-09-02 1996-12-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 細胞の病的変化を検出する方法

Also Published As

Publication number Publication date
US5118606A (en) 1992-06-02
ES2077863T3 (es) 1995-12-01
JPH1130615A (ja) 1999-02-02
ATE128233T1 (de) 1995-10-15
JPH05508919A (ja) 1993-12-09
EP0540591B1 (de) 1995-09-20
DE69113273T2 (de) 1996-05-15
GR3017459T3 (en) 1995-12-31
EP0540591A1 (de) 1993-05-12
WO1992001935A1 (en) 1992-02-06
CA2088050A1 (en) 1992-01-27
JP2824150B2 (ja) 1998-11-11
DK0540591T3 (da) 1996-02-05

Similar Documents

Publication Publication Date Title
DE69113273T2 (de) Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.
DE69409401D1 (de) Schnelles immunologisches testverfahren zum nachweis von antikörpern oder antigenen einschliesslich gleichzeitiger nachweis probenextraktion und immunogener reaktion
IT8019675A0 (it) Procedimento per rivelare ligandi in campioni di prova e relativo reagente analitico.
DE68928007D1 (de) Antigene Zusammensetzungen aus Fragmenten von Campylobacter pylori und Verfahren zu ihrer Herstellung und Verwendung
IT1190152B (it) Provino per la valutazione dei risultati di esami non distruttivi di materiali,nonche' elementi di difetto e procedimento per preparare provini
Ronald Review of current techniques for the verification of the species origin of meat
JPH059745B2 (de)
ES2192611T3 (es) Procedimiento de eliminacion de la interferencia del factor reumatoide en los dosificados de diagnostico.
Blancher et al. SDS-PAGE and western blotting techniques
ES501734A0 (es) Un procedimiento para la deteccion de anticuerpos en una muestra de ensayo
Kristensen et al. Expression of Na+/HCO3− co‐transporter proteins (NBCs) in rat and human skeletal muscle
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
EP0254081A3 (de) Verfahren zur Feststellung spezifisches Protein
DK33991A (da) Fremgangsmaade til paavisning af cellepatologi
Goodburn et al. A simple micro-ELISA method for the assay of antithyroglobulin autoantibodies in human serum
EP0028133A3 (de) Verfahren zum Nachweis und zur Mengenbestimmung von Haptenen und Antigenen
Allsup A comparison of the agar gel immuno-diffusion (AGID) and counter-immunoelectrophoresis (CIE) tests for species identification of imported red meat and offal
EP0204579A3 (de) Immunoassay-Inkubationsapparat
DK162726C (da) Fremgangsmaade til eliminering af falsk positive resultater ved bestemmelse af atl virus-antistof og reagens dertil
Okajima et al. Quantitative analysis of species identification tests of bloodstains using anti-human serum
DE58907725D1 (de) Mittel für immunchemische Tests enthaltend Aminoxide.
Ottó et al. Sensitized immunochemical method for the specific detection of human haemoglobin in dried biological samples
SU928191A1 (ru) Способ определени радиационной стойкости полимерных материалов
Ford et al. The detection of autoantibodies with an enzyme bridge method
Sheng et al. Electroimmunoblotting of myelin basic protein peptides: a novel approach to the rapid characterisation of antigenic specificities of monoclonal and polyclonal anti-MBP antibodies

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee